UiPath stock drops before the bell as risk-off trade bites; PATH earnings next week loom

UiPath stock drops before the bell as risk-off trade bites; PATH earnings next week loom

March 2, 2026

New York, March 2, 2026, 07:48 EST — Premarket

  • UiPath slipped roughly 2.6% before the bell, after finishing the previous session at $10.73.
  • U.S. futures dropped, while oil surged, as the Middle East conflict cast a deeper shadow over the outlook.
  • With March 11 results on the radar, traders are bracing for an outsized move, according to signals from the options market.

UiPath, Inc dropped 2.6% to $10.46 before the bell on Monday, retreating after investors trimmed positions in riskier software stocks. The shares previously ended at $10.73.

Sellers hit the market as U.S. stock index futures dropped more than 1%, with crude surging roughly 8% after conflict flared in the Middle East and traders piled into the dollar and other safe bets. “There is plenty of scope for more downside,” said IG chief market analyst Chris Beauchamp, adding that losses could intensify if energy infrastructure gets caught up in the turmoil. Reuters

UiPath investors find themselves in a tricky spot. The company’s quarterly numbers are just days away, with shares reacting to both broad market jitters and uncertainty over the pace at which clients will start spending on automation projects again.

UiPath is slated to release its fourth-quarter and full-year fiscal 2026 numbers after the bell on Wednesday, March 11. The company’s conference call is on deck for 5:00 p.m. ET.

Options markets are signaling nerves ahead of the print, with 30-day implied volatility hovering close to 95, according to data from TheFly. That level points to options pricing that’s anticipating a double-digit move when earnings land. Implied volatility tracks trader expectations for stock swings.

On another front, some traders flagged three Form 4 filings posted Feb. 27 on UiPath’s investor relations page—these are the disclosures tracking insider transactions.

UiPath, known for its software that automates repetitive, rules-driven tasks—a field often labeled robotic process automation—has also started pushing “agentic” tools, which are designed for more advanced workflows.

For now, the market is watching just a few things: subscription demand, renewals, and whatever management says about how fast deals are closing next quarter. If there’s even a whiff of spending cuts—particularly from big clients—the stock usually reacts fast.

The risk cuts both ways. Should oil prices remain high and risk appetite continue to ebb in U.S. stocks, high-beta software names could drop, even in the absence of fresh headlines. Throw in a cautious outlook next week, and it could be a recipe for more selling.

Konrad Wysocki

Konrad Wysocki is a senior markets reporter at Bez-kabli.pl, specializing in technology stocks, artificial intelligence and global financial markets. A graduate of the University of Rzeszów, he previously worked in investment research and market analysis. His coverage helps readers understand the key trends, companies and innovations influencing investors worldwide.

Stock Market Today

  • Telix Pharmaceuticals (ASX:TLX) and Predictive Discovery (ASX:PDI) Draw Attention on Insider Ownership, Growth
    July 27, 2026, 1:30 PM EDT. Investors are looking at companies with both strong insider ownership and visible growth paths as inflation and central banks shape the market. Telix Pharmaceuticals (ASX:TLX), with a market cap of A$5.0 billion, claims a spot in radiopharmaceuticals for cancer and has a US presence and late-stage clinical trials. Predictive Discovery (ASX:PDI), a gold explorer at A$3.1 billion, is developing West African projects but comes with financial and dilution risks highlighted by recent losses. Both names mix growth stories with insider backing, but their risk profiles vary, giving investors a range of growth-focused, insider-led picks for watchlists.